• 2023
  Lakosa A, Rahimian A, Tomasi F, Marti F, Reynolds LM, Tochon L, David V, Danckaert A, Canonne C, Tahraoui S, de Chaumont F, Forget B, Maskos U, Besson M, Impact of the gut microbiome on nicotine’s motivational effects and glial cells in the ventral tegmental area in male mice., Neuropsychopharmacology 2023 May; 48(6): 963-974.
• 2023
  Ferhat AT, Verpy E, Biton A, Forget B, De Chaumont F, Mueller F, Le Sourd AM, Coqueran S, Schmitt J, Rochefort C, Rondi-Reig L, Leboucher A, Boland A, Fin B, Deleuze JF, Boeckers TM, Ey E, Bourgeron T, , Excessive self-grooming, gene dysregulation and imbalance between the striosome and matrix compartments in the striatum of Shank3 mutant mice., Front Mol Neurosci 2023 ; 16(): 1139118.
• 2021
  Forget B, Garcia EM, Godino A, Rodriguez LD, Kappes V, Poirier P, Andrianarivelo A, Marchan ES, Allichon MC, Marias M, Vanhoutte P, Girault JA, Maldonado R, Caboche J, , Cell-type- and region-specific modulation of cocaine seeking by micro-RNA-1 in striatal projection neurons., Mol Psychiatry 2021 Nov; (): .
• 2021
  Lissek T, Andrianarivelo A, Saint-Jour E, Allichon MC, Bauersachs HG, Nassar M, Piette C, Pruunsild P, Tan YW, Forget B, Heck N, Caboche J, Venance L, Vanhoutte P, Bading H, , Npas4 regulates medium spiny neuron physiology and gates cocaine-induced hyperlocomotion., EMBO Rep 2021 Oct; (): e51882.
• 2021
  Butler K, Forget B, Heishman SJ, Le Foll B, , Significant association of nicotine reinforcement and cue reactivity: a translational study in humans and rats., Behav Pharmacol 2021 04; 32(2&3): 212-219.
• 2021
  Forget B, Icick R, Robert J, Correia C, Prevost MS, Gielen M, Corringer PJ, Bellivier F, Vorspan F, Besson M*, Maskos U* , Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients., Prog Neurobiol 2021 02; 197(): 101898.
• 2019
  Besson M, Forget B, Correia C, Blanco R, Maskos U, , Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior., Neuropsychopharmacology 2019 10; 44(11): 1906-1916.
• 2018
  Forget B, Scholze P, Langa F, Morel C, Pons S, Mondoloni S, Besson M, Durand-de Cuttoli R, Hay A, Tricoire L, Lambolez B, Mourot A, Faure P, Maskos U, , A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats., Curr Biol 2018 Oct; 28(20): 3244-3253.e7.
• 2017
  Dos Santos M, Salery M, Forget B, Garcia Perez MA, Betuing S, Boudier T, Vanhoutte P, Caboche J, Heck N., Rapid Synaptogenesis in the Nucleus Accumbens Is Induced by a Single Cocaine Administration and Stabilized by Mitogen-Activated Protein Kinase Interacting Kinase-1 Activity., Biol Psychiatry. 2017 Dec 1;82(11):806-818. doi: 10.1016/j.biopsych.2017.03.014. Epub 2017 Mar 29.
• 2016
  Besson M, Forget B., Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective., Front Psychiatry. 2016 Sep 21;7:160.
• 2016
  Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B, Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats, Psychopharmacology (Berl.) 2016 Feb;.
• 2013
  Le Foll B, Pushparaj A, Pryslawsky Y, Forget B, Vemuri K, Makriyannis A, Trigo JM, Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approach, Prog. Neuropsychopharmacol. Biol. Psychiatry 2014 Jul;52:86-93.
• 2012
  Pushparaj A, Pryslawsky Y, Forget B, Yan Y, Le Foll B, Extinction bursts in rats trained to self-administer nicotine or food in 1-h daily sessions, Am J Transl Res 2012;4(4):422-31.
• 2010
  Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B, Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction, Neuropsychopharmacology 2010 Jul;35(8):1751-60.
• 2010
  Forget B, Pushparaj A, Le Foll B, Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction, Biol. Psychiatry 2010 Aug;68(3):265-71.
• 2009
  Forget B, Coen KM, Le Foll B, Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration–comparison with CB(1) receptor blockade, Psychopharmacology (Berl.) 2009 Sep;205(4):613-24.
• 2009
  Forget B, Hamon M, Thiébot MH, Involvement of alpha1-adrenoceptors in conditioned place preference supported by nicotine in rats, Psychopharmacology (Berl.) 2009 Aug;205(3):503-15.
• 2008
  Scherma M, Fadda P, Le Foll B, Forget B, Fratta W, Goldberg SR, Tanda G, The endocannabinoid system: a new molecular target for the treatment of tobacco addiction, CNS Neurol Disord Drug Targets 2008 Nov;7(5):468-81.
• 2008
  Le Foll B, Forget B, Aubin HJ, Goldberg SR, Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies, Addict Biol 2008 Jun;13(2):239-52.
• 2007
  Ramaz F, Bossy E, Dubois A, Gigan S, Forget B, Gross M, Boccara AC, Optical imaging in biological tissue: taking advantage of the light coherence properties, Conf Proc IEEE Eng Med Biol Soc 2007;2007:520.
• 2006
  Forget B, Barthélémy S, Saurini F, Hamon M, Thiébot MH, Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats, Psychopharmacology (Berl.) 2006 Nov;189(1):59-69.
• 2005
  Forget B, Hamon M, Thiébot MH, Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats, Psychopharmacology (Berl.) 2005 Oct;181(4):722-34.